Cite
HARVARD Citation
Yamamoto, Y. et al. (2022). Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS). Cancer science. 113 (9), pp. 3169-3179. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamamoto, Y. et al. (2022). Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS). Cancer science. 113 (9), pp. 3169-3179. [Online].